Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)
Fennec Pharmaceuticals' (FENC) quarterly Capital Expenditures came in at $1.7 million in Q1 2024.
Analysis
Fennec Pharmaceuticals (FENC) Capital Expenditures (2024) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 1 years of Capital Expenditures data on file, last reported at $1.7 million in Q1 2024.
- Quarterly Capital Expenditures changed N/A year-over-year to $1.7 million in Q1 2024, while the trailing twelve-month figure through Jun 2024 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.8 million, changed N/A from the prior year.
- Capital Expenditures was little changed at $1.7 million in Q1 2024.
- In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q1 2024 to a low of $1.7 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |